Technology Investment for Advanced Therapies: Investing in the Future
20 Jan 2023
11:00
Commercializing the Therapies of the Future Track
11:00am Chair Introduction
Julie Lenzer, Chief Innovation Officer, Advanced Regenerative Manufacturing Institute (ARMI)
11:05am Presentation: Secrets in the Pitch – Lessons Learned in Fund-Raising in Cell & Gene Therapy
• What do investors really want to hear, and more importantly
• What do you think they want to hear – but they really don’t
Bryan Poltilove, Operating Partner, BroadOak Capital Partners & Xavier de Mollerat du Jeu, Senior Director R&D, Thermo Fisher Scientific
11:20am Presentation: Latest Innovative Technologies and Investments in Immuno-oncology”
- iPS cells
- Cloaking/hypoimmunogenic cells
- In vivo CAR-T
Stefanos Theoharis, Core Team Member, Cell One Partners
11:35am Closing Panel with Q&A
Joined by Jacob Becraft, CEO, Strand Therapeutics
Speakers
